FALLETTA, ANTONIO
FALLETTA, ANTONIO
Comparison of clinical features and outcomes in COVID-19 and influenza pneumonia patients requiring intensive care unit admission
2021 Oliva, A; Ceccarelli, G; Borrazzo, C; Ridolfi, M; D'Ettorre, G; Alessandri, F; Ruberto, F; Pugliese, F; Raponi, G M; Russo, A; Falletta, A; Mastroianni, C M; Venditti, M
Efficacy of Fosfomycin-Containing Regimens in Treating Severe Infections Caused by KPC-Producing Klebsiella pneumoniae and Carbapenem-Resistant Acinetobacter baumannii in Critically Ill Patients
2024 Oliva, A.; Curtolo, A.; Falletta, A.; Sacco, F.; Lancellotti, F.; Carnevalini, M.; Ceccarelli, G.; Roma, G.; Bufi, M.; Magni, G.; Raponi, G. M.; Venditti, M.; Mastroianni, C. M.
Midregional-proAdrenomedullin as a prognostic tool in sepsis and septic shock: A systematic review and meta-analysis
2024 Valeriani, Emanuele; Falletta, Antonio; Pastori, Daniele; Porfidia, Angelo; Mastroianni, Claudio Maria; DI BARI, Silvia; Motta, Eleonora; Pignatelli, Pasquale; Oliva, Alessandra
Midregional‐proAdrenomedullin as a prognostic tool in sepsis and septic shock. A systematic review and meta‐analysis
2024 Valeriani, Emanuele; Falletta, Antonio; Pastori, Daniele; Porfidia, Angelo; Mastroianni, Claudio Maria; Di , ; Bari, Silvia; Motta, Eleonora; Pignatelli, Pasquale; Oliva, Alessandra
New antimicrobials and new therapy strategies for endocarditis. Weapons that should be defended
2023 Oliva, Alessandra; Cogliati Dezza, Francesco; Cancelli, Francesca; Curtolo, Ambrogio; Falletta, Antonio; Volpicelli, Lorenzo; Venditti, Mario
Real-world use of imipenem/cilastatin/relebactam for the treatment of KPC-producing Klebsiella pneumoniae complex and difficult-to-treat resistance (DTR) Pseudomonas aeruginosa infections. A single-center preliminary experience
2024 Leanza, Cristiana; Mascellino, Maria Teresa; Volpicelli, Lorenzo; Covino, Sara; Falletta, Antonio; Cancelli, Francesca; Franchi, Cristiana; Carnevalini, Martina; Mastroianni, Claudio M; Oliva, Alessandra
Safety evaluation of current therapies for high-risk severely ill patients with carbapenem-resistant infections
2021 Bassetti, Matteo; Falletta, Antonio; Cenderello, Giovanni; Giacobbe, Daniele R.; Vena, Antonio
Trajectories of CD4+/CD8+ T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study
2022 Taramasso, Lucia; Falletta, Antonio; Ricci, Elena; Orofino, Giancarlo; Squillace, Nicola; Menzaghi, Barbara; De Socio, Giuseppe; Molteni, Chiara; Pellicanò, Giovanni; Gulminetti, Roberto; Madeddu, Giordano; Sarchi, Eleonora; Vichi, Francesca; Celesia, Benedetto; Bonfanti, Paolo; Di Biagio, Antonio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Comparison of clinical features and outcomes in COVID-19 and influenza pneumonia patients requiring intensive care unit admission | 2021 | Oliva, A; Ceccarelli, G; Borrazzo, C; Ridolfi, M; D'Ettorre, G; Alessandri, F; Ruberto, F; Pugliese, F; Raponi, G M; Russo, A; Falletta, A; Mastroianni, C M; Venditti, M | |
| Efficacy of Fosfomycin-Containing Regimens in Treating Severe Infections Caused by KPC-Producing Klebsiella pneumoniae and Carbapenem-Resistant Acinetobacter baumannii in Critically Ill Patients | 2024 | Oliva, A.; Curtolo, A.; Falletta, A.; Sacco, F.; Lancellotti, F.; Carnevalini, M.; Ceccarelli, G.; Roma, G.; Bufi, M.; Magni, G.; Raponi, G. M.; Venditti, M.; Mastroianni, C. M. | |
| Midregional-proAdrenomedullin as a prognostic tool in sepsis and septic shock: A systematic review and meta-analysis | 2024 | Valeriani, Emanuele; Falletta, Antonio; Pastori, Daniele; Porfidia, Angelo; Mastroianni, Claudio Maria; DI BARI, Silvia; Motta, Eleonora; Pignatelli, Pasquale; Oliva, Alessandra | |
| Midregional‐proAdrenomedullin as a prognostic tool in sepsis and septic shock. A systematic review and meta‐analysis | 2024 | Valeriani, Emanuele; Falletta, Antonio; Pastori, Daniele; Porfidia, Angelo; Mastroianni, Claudio Maria; Di , ; Bari, Silvia; Motta, Eleonora; Pignatelli, Pasquale; Oliva, Alessandra | |
| New antimicrobials and new therapy strategies for endocarditis. Weapons that should be defended | 2023 | Oliva, Alessandra; Cogliati Dezza, Francesco; Cancelli, Francesca; Curtolo, Ambrogio; Falletta, Antonio; Volpicelli, Lorenzo; Venditti, Mario | |
| Real-world use of imipenem/cilastatin/relebactam for the treatment of KPC-producing Klebsiella pneumoniae complex and difficult-to-treat resistance (DTR) Pseudomonas aeruginosa infections. A single-center preliminary experience | 2024 | Leanza, Cristiana; Mascellino, Maria Teresa; Volpicelli, Lorenzo; Covino, Sara; Falletta, Antonio; Cancelli, Francesca; Franchi, Cristiana; Carnevalini, Martina; Mastroianni, Claudio M; Oliva, Alessandra | |
| Safety evaluation of current therapies for high-risk severely ill patients with carbapenem-resistant infections | 2021 | Bassetti, Matteo; Falletta, Antonio; Cenderello, Giovanni; Giacobbe, Daniele R.; Vena, Antonio | |
| Trajectories of CD4+/CD8+ T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study | 2022 | Taramasso, Lucia; Falletta, Antonio; Ricci, Elena; Orofino, Giancarlo; Squillace, Nicola; Menzaghi, Barbara; De Socio, Giuseppe; Molteni, Chiara; Pellicanò, Giovanni; Gulminetti, Roberto; Madeddu, Giordano; Sarchi, Eleonora; Vichi, Francesca; Celesia, Benedetto; Bonfanti, Paolo; Di Biagio, Antonio |